Metosyn

Fluocinonide, the active ingredient in Metosyn, is a potent corticosteroid presented as a topical formulation for skin application. It is used to reduce inflammation and immune responses in various dermatologic conditions, providing relief for patients with chronic or acute skin disorders. GNH USA supplies Metosyn as a licensed, GDP‑compliant international pharmaceutical product to hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and regulatory requirements across EU and global markets.

Fluocinonide is a high‑potency topical corticosteroid that modulates inflammatory pathways in skin disorders.

- Psoriasis: alleviates scaling, erythema and plaque thickness by suppressing local inflammation. - Eczema: reduces itching, redness and edema through anti‑inflammatory action. - Dermatitis: controls acute flare‑ups by inhibiting immune cell activation. - Lichen planus: diminishes lesions and discomfort by limiting cytokine‑mediated damage.

Topical fluocinonide may cause local and systemic adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Burning or stinging at the application site. - Pruritus or mild itching. - Dryness or peeling of the skin. - Redness or mild erythema. - Folliculitis or small pustules. - Skin atrophy with prolonged use.

Serious or Rare Side Effects: - Adrenal suppression leading to systemic corticosteroid effects. - Severe allergic reactions such as contact dermatitis or urticaria. - Secondary bacterial, fungal or viral skin infections. - Development of striae, telangiectasia, or permanent skin thinning. - Delayed wound healing or ulceration.

When prescribing or using Metosyn, consider the following safety measures.

- Limit duration of use: apply for the shortest period needed to control symptoms. - Avoid large surface areas: restrict application to affected areas only. - Do not use on infected or ulcerated skin: may worsen infection. - Avoid occlusive dressings unless directed: can increase systemic absorption. - Use lowest effective potency: reduces risk of skin atrophy. - Store at room temperature: keep in original container, protect from moisture and light.

Fluocinonide may interact with other medications; awareness of interaction severity helps guide safe use.

Major Interactions (Avoid): - Systemic corticosteroids: additive systemic effects and increased risk of adrenal suppression. - Immunosuppressants (e.g., cyclosporine): heightened susceptibility to infections.

Moderate Interactions (Monitor Closely):\n- Antibiotics applied to the same area: may mask signs of infection. - Photosensitizing agents (e.g., tetracyclines): increased risk of skin irritation. - Live vaccines: potential reduction in vaccine efficacy due to local immunosuppression.